| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2006;37:1953.)
© 2006 American Heart Association, Inc.
Cochrane Corner |
From the Department of Diving and Hyperbaric Medicine (M.H.B.), Prince of Wales Hospital, Randwick, NSW, Australia; Burns, The Alfred Hospital Melbourne (J.W.), Australia; Department of Neurology (C.F.), Prince of Wales Hospital, Randwick, NSW, Australia; Department of Anesthesiology (P.K.), University Hospital Würzburg, Germany; and University of Würzburg (A.S.), Germany.
Correspondence to Michael H. Bennett, Prince of Wales Hospital, Barker St, Randwick, NSW 2031, Australia. E-mail m.bennett{at}unsw.edu.au
Key Words: brain infarction hyperbaric oxygenation meta-analysis
| Introduction |
|---|
|
|
|---|
HBOT is the therapeutic administration of 100% oxygen at pressures >1 atmosphere (101.3 kPa). Typically, treatments involve pressurization to between 152 and 304 kPa for periods between 60 and 120 minutes daily. The potential benefits of HBOT include a reduction of cerebral edema, decreased lipid peroxidation, inhibition of leukocyte activation, and restoration of the functional bloodbrain barrier.2,3 Conversely, oxygen in high doses may increase oxidative stress through the production of oxygen free-radical species, and the brain is particularly at risk.4
| Objective |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
Main Results
Three small randomized controlled trials (total 106 participants) were included in analysis. There were no statistically significant differences in mortality rate at 3 to 6 months in those receiving HBOT compared with control (relative risk, 0.61; 95% CI, 0.17 to 2.2; P=0.45; Figure). Two of 15 scale measures of disability or function indicated an improvement after HBOT, both at 1-year follow-up; the mean Trouillas Disability Scale was lower with HBOT (mean difference [MD] 2.2 points; 95% CI, 0.15 to 4.3; P=0.04), and the mean Orgogozo Scale was higher (MD, 27.9 points; 95% CI, 4.0 to 51.8; P=0.02). These improvements were not evident in previous assessments nor reflected in the other 13 functional scales recorded.
|
| Conclusions |
|---|
|
|
|---|
Implications for Research
Given the small number of participants in the trials included, we cannot be certain that a benefit from HBOT has been excluded. Although there is a case for further trials, such investigations would need to be carefully planned. More information may be useful on a subset of disease severity and the timing of therapy. The effect of differing oxygen dosage and of other therapies administered simultaneously is not known.
Note: The full text, data tables, analyses, results, and reference list of this article are available in the Cochrane Library. The full text article should be cited as: Bennett MH, Wasiak J, Schnabel A, Kranke P, French C. Hyperbaric oxygen therapy for acute ischemic stroke. The Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD004954. DOI: 10.1002/14651858.CD004954.pub2.
The Cochrane Library is available at: http://www3. interscience.wiley.com/cgi-bin/mrwhome/106568753/HOME. Reprints of the full-text version are available online from this site.
| Acknowledgments |
|---|
Disclosures
None.
Received January 13, 2006; accepted January 24, 2006.
| References |
|---|
|
|
|---|
2. Thom SR. Functional inhibition of leukocyte B2 integrins by hyperbaric oxygen in carbon monoxide-mediated brain injury in rats. Toxicol Appl Pharmacol. 1993; 123: 248256.[CrossRef][Medline] [Order article via Infotrieve]
3. Mink RB, Dutka AJ. Hyperbaric oxygen after global cerebral ischemia in rabbits reduces brain vascular permeability and blood flow. Stroke. 1995; 26: 23072312.
4. Clark JM. Oxygen toxicity. In: Bennett PB, Elliott DH, eds. The Physiology and Medicine of Diving. 3rd ed. London, UK: Bailliere, Tindall, and Cox; 1982: 200238.
5. Bennett MH, Connor D. The database of randomized controlled trials in diving and hyperbaric medicine. Available at: www.hboevidence.com. Accessed December 2005.
This article has been cited by other articles:
![]() |
M. Bennett, J. Wasiak, C. French, P. Kranke, and A. Schnabel Response to Letter by Helms et al Stroke, April 1, 2007; 38(4): 1138 - 1139. [Full Text] [PDF] |
||||
![]() |
A. K. Helms, H. T. Whelan, and M. T. Torbey Hyperbaric Oxygen Therapy of Acute Ischemic Stroke Stroke, April 1, 2007; 38(4): 1137 - 1137. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |